Snapshot
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
The global Overactive Bladder Treatment market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Overactive Bladder Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Anticholinergics
Mirabegron
Botox
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
North America
Europe
Asia-Pacific
South America
Middle East & Africa